190 related articles for article (PubMed ID: 16470212)
1. Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.
Sauthoff H; Pipiya T; Chen S; Heitner S; Cheng J; Huang YQ; Rom WN; Hay JG
Cancer Gene Ther; 2006 Jul; 13(7):686-95. PubMed ID: 16470212
[TBL] [Abstract][Full Text] [Related]
2. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
3. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.
O'Shea CC; Johnson L; Bagus B; Choi S; Nicholas C; Shen A; Boyle L; Pandey K; Soria C; Kunich J; Shen Y; Habets G; Ginzinger D; McCormick F
Cancer Cell; 2004 Dec; 6(6):611-23. PubMed ID: 15607965
[TBL] [Abstract][Full Text] [Related]
4. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells.
Wei F; Wang H; Chen X; Li C; Huang Q
Cancer Biol Ther; 2014 Oct; 15(10):1358-66. PubMed ID: 25019940
[TBL] [Abstract][Full Text] [Related]
6. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene.
Hay JG; Shapiro N; Sauthoff H; Heitner S; Phupakdi W; Rom WN
Hum Gene Ther; 1999 Mar; 10(4):579-90. PubMed ID: 10094201
[TBL] [Abstract][Full Text] [Related]
7. Infection with E1B-mutant adenovirus stabilizes p53 but blocks p53 acetylation and activity through E1A.
Savelyeva I; Dobbelstein M
Oncogene; 2011 Feb; 30(7):865-75. PubMed ID: 20935676
[TBL] [Abstract][Full Text] [Related]
8. E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.
Hobom U; Dobbelstein M
J Virol; 2004 Jul; 78(14):7685-97. PubMed ID: 15220443
[TBL] [Abstract][Full Text] [Related]
9. DNA replication of first-generation adenovirus vectors in tumor cells.
Steinwaerder DS; Carlson CA; Lieber A
Hum Gene Ther; 2000 Sep; 11(13):1933-48. PubMed ID: 10986565
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.
Yang H; Zheng Z; Zhao LY; Li Q; Liao D
Cell Cycle; 2012 Feb; 11(3):582-93. PubMed ID: 22262167
[TBL] [Abstract][Full Text] [Related]
11. Self-association of adenovirus type 5 E1B-55 kDa as well as p53 is essential for their mutual interaction.
Morawska-Onyszczuk M; Bieńkowska-Szewczyk K; Dobbelstein M
Oncogene; 2010 Mar; 29(12):1773-86. PubMed ID: 20023703
[TBL] [Abstract][Full Text] [Related]
12. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
[TBL] [Abstract][Full Text] [Related]
13. Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector.
Sauthoff H; Heitner S; Rom WN; Hay JG
Hum Gene Ther; 2000 Feb; 11(3):379-88. PubMed ID: 10697113
[TBL] [Abstract][Full Text] [Related]
14. Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein.
Sauthoff H; Pipiya T; Heitner S; Chen S; Norman RG; Rom WN; Hay JG
Hum Gene Ther; 2002 Oct; 13(15):1859-71. PubMed ID: 12396618
[TBL] [Abstract][Full Text] [Related]
15. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
[TBL] [Abstract][Full Text] [Related]
16. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells.
Steegenga WT; Riteco N; Jochemsen AG; Fallaux FJ; Bos JL
Oncogene; 1998 Jan; 16(3):349-57. PubMed ID: 9467960
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of p53 by adenovirus type 12 E1B-55K deregulates cell cycle control and sensitizes tumor cells to genotoxic agents.
Li Q; Zhao LY; Zheng Z; Yang H; Santiago A; Liao D
J Virol; 2011 Aug; 85(16):7976-88. PubMed ID: 21680522
[TBL] [Abstract][Full Text] [Related]
18. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
19. Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas.
Jiang H; Gomez-Manzano C; Alemany R; Medrano D; Alonso M; Bekele BN; Lin E; Conrad CC; Yung WK; Fueyo J
Neoplasia; 2005 Jan; 7(1):48-56. PubMed ID: 15720816
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic E1B 55KDa-deleted adenovirus replication is independent of p53 levels in cancer cells.
Abbas BM; El-Mogy MA; Haj-Ahmad Y
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(7):1-11. PubMed ID: 28838332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]